Medical Device MDR CER Writing Fees

In the global context of CER writing medical device manufacturers and their regulatory teams are currently grappling with a sense of confusion and ambiguity in relation to EU MDR Article 61 and the intricacies of crafting and documenting Clinical Evaluation Reports (CERs) following the guidelines outlined in MEDDEV 2.7/1 Revision 4.

Our CER writing consultants and subject matter experts  has invested substantial time and effort in conducting thorough research, which has led to the accumulation of valuable expertise in comprehending the strategies essential for the successful documentation of a clinical evaluation report which satisfies the Notified Body requirements.

If your organization has genuine interest in the process of either revising an existing MDD Clinical Evaluation Report or initiating the development of a new one, taking into consideration the regulations specified in Article 61, we kindly request that you examine the pricing information provided below, tailored to your specific device class.